SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-032355
Filing Date
2021-02-08
Accepted
2021-02-08 16:12:35
Documents
12
Period of Report
2021-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d66261d8ka.htm   iXBRL 8-K/A 23109
  Complete submission text file 0001193125-21-032355.txt   145172

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210106.xsd EX-101.SCH 3081
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210106_lab.xml EX-101.LAB 18086
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210106_pre.xml EX-101.PRE 11400
5 EXTRACTED XBRL INSTANCE DOCUMENT d66261d8ka_htm.xml XML 3569
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34655 | Film No.: 21601546
SIC: 2834 Pharmaceutical Preparations